iShares Trust - iShares Biotechnology ETF
GB ˙ LSE ˙ US4642875565
131,05 $ ↓ -0,77 (-0,58%)
2023-12-18
DEL PRIS
SecurityGB:0JGB / iShares Trust - iShares Biotechnology ETF
InstitutionBeck Capital Management, Llc
Latest Disclosed Ownership2,003 shares
Latest Disclosed Value $ 338,167
Beck Capital Management, Llc reports 12.34% increase in ownership of 0JGB / iShares Trust - iShares Biotechnology ETF

On May 15, 2026 - Beck Capital Management, Llc filed a 13F-HR form disclosing ownership of 2,003 shares of iShares Trust - iShares Biotechnology ETF (GB:0JGB) valued at $338,167 USD as of March 31, 2026. The entity filed a previous 13F-HR on February 13, 2026 disclosing 1,783 shares of iShares Trust - iShares Biotechnology ETF. This represents a change in shares of 12.34% during the quarter. The current value of the position is $262,493 USD.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date		 Effective
Date		Form Security Class ID Avg Price
Paid (Est)		 Reported
Shares		 ΔShares ΔShares
(%)		 Reported
Value
(x1000)		 ΔValue
(%)		 Alloc
(%)		 ΔAlloc ΔAlloc (%) Cost Basis
(x1000)		 Unrealized
Gain/Loss
(x1000)
2026-05-15 2026-03-31 13F ISHARES TR ISHARES BIOTECH 464287556 2,003 220 12.34 338 12.67 0.0774
2026-02-13 2025-12-31 13F ISHARES TR ISHARES BIOTECH Equity 464287556 1,783 1,783 301 0.0716
2023-08-14 2023-06-30 13F ISHARES TR ISHARES BIOTECH Equities 464287556 0 -13,262 -100.00 0 -100.00
2023-05-15 2023-03-31 13F ISHARES TR ISHARES BIOTECH Equities 464287556 13,262 13,262 1,713 0.7289
2022-02-14 2021-12-31 13F ISHARES TR ISHARES BIOTECH Equities 464287556 0 -26,199 -100.00 0 -100.00
2021-11-12 2021-09-30 13F ISHARES TR ISHARES BIOTECH Equities 464287556 26,199 11,909 83.34 4,236 81.18 1.4229
2021-08-13 2021-06-30 13F ISHARES TR ISHARES BIOTECH Equities 464287556 14,290 -126 -0.87 2,338 7.74 0.7866
2021-05-14 2021-03-31 13F ISHARES TR Equities 464287556 14,416 -9 -0.06 2,170 -0.69 0.8185
2021-02-12 2020-12-31 13F ISHARES TR NASDAQ BIOTECH Equities 464287556 14,425 -1,180 -7.56 2,185 3.41 0.9074
2020-11-13 2020-09-30 13F ISHARES TR Equities 464287556 15,605 -1,004 -6.04 2,113 -6.92 1.1946
2020-08-14 2020-06-30 13F ISHARES TR NASDAQ BIOTECH Equities 464287556 16,609 16,609 2,270 1.1498
2019-11-14 2019-09-30 13F ISHARES TR NASDAQ BIOTECH Equities 464287556 0 -7,462 -100.00 0 -100.00
2019-08-14 2019-06-30 13F ISHARES TR NASDAQ BIOTECH Equities 464287556 7,462 -595 -7.38 814 -9.66 0.4294
2019-05-15 2019-03-31 13F ISHARES TR NASDAQ BIOTECH Equities 464287556 8,057 5,732 246.54 901 302.23 0.4306
2019-02-14 2018-12-31 13F ISHARES TR NASDAQ BIOTECH Equities 464287556 2,325 -1,382 -37.28 224 -50.44 0.1920
2018-11-14 2018-09-30 13F ISHARES TR NASDAQ BIOTECH Equity 464287556 3,707 0 0.00 452 11.06 0.1943
2018-08-14 2018-06-30 13F ISHARES TR NASDAQ BIOTECH Equity 464287556 3,707 -846 -18.58 407 -16.26 0.1968
2018-05-15 2018-03-31 13F ISHARES TR NASDAQ BIOTECH Equity 464287556 4,553 -130 -2.78 486 -2.80 0.2237
2018-02-14 2017-12-31 13F ISHARES TR NASDAQ BIOTECH Equity 464287556 4,683 3,163 208.09 500 -1.38 0.2202
2017-11-14 2017-09-30 13F ISHARES TR NASDAQ BIOTECH Equity 464287556 1,520 788 107.65 507 116.67 0.2421
2017-08-14 2017-06-30 13F ISHARES NASDAQ BIOTECHNOLOGY ETF Equity 464287556 732 732 234 0.1201
2016-05-13 2016-03-31 13F ISHARES NASDAQ BIOTECHNOLOGY ETF Equity 464287556 0 -6,100 -100.00 0 -100.00
2016-02-12 2015-12-31 13F ISHARES NASDAQ BIOTECHNOLOGY ETF Equity 464287556 6,100 -573 -8.59 2,064 2.43 1.2148
2015-11-13 2015-09-30 13F ISHARES NASDAQ BIOTECHNOLOGY ETF Equity 464287556 6,673 -1,391 -17.25 2,015 -32.29 1.3973
2015-08-14 2015-06-30 13F ISHARES NASDAQ BIOTECHNOLOGY ETF Equity 464287556 8,064 570 7.61 2,976 15.62 1.5926
2015-05-14 2015-03-31 13F ISHARES NASDAQ BIOTECHNOLOGY ETF Equity 464287556 7,494 12 0.16 2,574 13.39 1.4718
2015-02-12 2014-12-31 13F ISHARES NASDAQ BIOTECHNOLOGY ETF Equity 464287556 7,482 501 7.18 2,270 21.33 1.3234
2014-11-13 2014-09-30 13F ISHARES NASDAQ BIOTECHNOLOGY ETF Equity 464287556 6,981 215 3.18 1,871 7.59 1.3167
2014-07-31 2014-06-30 13F ISHARES NASDAQ BIOTECHNOLOGY ETF Equity 464287556 6,766 -1,797 -20.99 1,739 -15.95 1.1554
2014-04-15 2014-03-31 13F ISHARES NASDAQ BIOTECHNOLOGY ETF Equity 464287556 8,563 -3,411 -28.49 2,069 -28.83 1.5815
2014-03-10 2013-12-31 13F ISHARES NASDAQ BIOTECHNOLOGY ETF Equity 464287556 11,974 11,974 2,907 2.3367
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.